S100A9 and COVID-19: Furthermore, S100A9 amplified the recombinant S2 protein of SARS-CoV-2-induced IL-1β mRNA expression in PBMCs in vitro (133), suggesting that activation of TLR4 by LPS from the gut microbiota of elderly, diabetic, and hypertensive individuals may be related to the severity of COVID-19.